Clinical Trials Browser

Phase 3 × Adenocarcinoma of Lung × lorlatinib × Clear all

NCT06858410 2025-03-05

Lorlatinib Compared with Concurrent/ Sequential Chemoradiotherapy in Stage III ALK Positive Lung Adenocarcinoma

Phase 3 Not yet recruiting

Adenocarcinoma of Lung